Modern oncologic care entails actively pursuing treatment and cure; however, at the end of life, the ability to share silence may be the best treatment.
Study findings indicate that nurses have lower ratings of satisfaction with care than those given by the general public.
What is the USP and what do I need to know about it as an oncology nurse?
LISTEN, a novel program developed at WVU School of Medicine, is designed to tackle loneliness — a significant health concern for patients with cancer.
A retrospective study of data from POGONIS evaluated the effectiveness of specialized pediatric palliative care vs general palliative care or no palliative care in pediatric patients with cancer at the end of life.
Although many physical expressions are universal, oncology nurses may be challenged to catch notice of more subtle body language from patients or a family member.
A cancer diagnosis is wrought with challenges for young adults. This article identifies the unique support needs for patients aged 20 to 39 years with cancer.
Perceptions of missed care are tied to higher patient-to-nurse ratios in England's hospitals, research indicates.
An analysis of select responses to a survey conducted by researchers from the College of Nursing at South Dakota State University identified oncology nurses' comfort level in handling end-of-life care and patient education.
Cultural humility is a different perspective on nurse-patient communication than cultural competence. Eucharia Borden, an oncology social worker, explains their difference and how it can improve your care for patients of minority cultures.
Should patients receiving chemotherapy take probiotics?
Cardio-oncology is an emerging interdisciplinary practice poised to address care patients who need concurrent cancer and cardiovascular disease therapies as well as the late effects of cancer and cancer treatments.
Groups urge Congress to take immediate action, provide transparency, and improve drug manufacturing.
A team from Dana-Farber Cancer Institute describe EMBRACE, their comprehensive care program for patients with metastatic breast cancer at SABCS 2017.
In this companion piece to our November column, we discuss the unique challenges to preserving the fertility of female patients with cancer and current options.
A palliative care family meeting is an opportunity for the significant players in a patient's cancer journey to discuss the care plan. The oncology nurse has a pivotal role in ensuring the meeting effectively addresses any potential needs of the patient, caregiver, or family.
Researchers evaluated the effectiveness of online learning modules on physical activity counseling for oncology nurses. Although the modules improved nurses' counseling practices, they did not resolve the issue of physical activity in survivors.
Increasing survival rates for AYA patients with cancer have heightened the importance of discussing fertility preservation options. In this column, we review the options for male patients and the significance of including a discussion of them as part of treatment planning.
As the holidays approach, offering these SUPPORT tips can help caregivers of patients with cancer make the most of the seasonal activities and the time with their loved ones.
A review of granulocyte colony-stimulating factors, dosage and administration, adverse effects, and nurse management steps is presented.
Nurses' critical thinking perspective is key to recognizing and managing adverse effects in patients with lymphoma, and staying ahead of the curve in a rapidly changing clinical setting.
Questionnaires completed before and after a clinic visit revealed the potential anxiety of patients during the diagnosis and treatment planning phases of their cancer journey.
Patients and caregivers are sure to ask for tips and advice on nutrition practices that can improve their cancer journey. This articles reviews recommendations for nurses and patients.
By 2020, roughly 64 percent of nurses working in a hospital unit are expected to have a BSN degree.
What is a CCDR clinical trial and how does it differ from clinical trials that test new drugs?
Using a 4-question survey, investigators determined oncology nurses' perception of their risks in handling and administering cytotoxic chemotherapy to patients.
When patients and families are holding on to what you don't say, they may use combativeness and being argumentative to keep you — and your words — from bringing them to accept the unacceptable.
As the use of checkpoint inhibitors increases in many types of cancer, oncology nurses need to learn to recognize the signs and symptoms of pneumonitis, a rare but life-threatening adverse effect of these agents.
The use of digital recording may aid in the transition from theory-based learning to practice.
Interviews with undergraduate nursing students revealed that many report bullying in both clinical and academic settings.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|